ACMUIs Position on Patient on Patient Release Release Pat - - PowerPoint PPT Presentation

acmui s position on patient on patient release release
SMART_READER_LITE
LIVE PREVIEW

ACMUIs Position on Patient on Patient Release Release Pat - - PowerPoint PPT Presentation

ACMUIs Position on Patient on Patient Release Release Pat Zanzonico, PhD, DABR ACMUI May 9, 2014 ACMUI, 12/10/10 Patient Release Report Medical use of radionuclides Widely recognized health benefits Public doses


slide-1
SLIDE 1

ACMUI’s Position

  • n Patient
  • n Patient Release

Release

Pat Zanzonico, PhD, DABR ACMUI May 9, 2014

slide-2
SLIDE 2

2

ACMUI, 12/10/10 “Patient Release Report”

  • Medical use of radionuclides
  • Widely recognized health benefits
  • Public doses  Background levels
  • Avoid burdensome regulatory control
  • Doses to other individuals can be safely controlled
  • Current 10 CFR 35.75 dose-based release criteria:

5-mSv (500-mrem) dose limit per event

  • Patient and caregiver post-release instructions

adapted to individual circumstances

  • 10 CFR 35.75 release criteria consistent with national

and internal dose-constraint standards

slide-3
SLIDE 3

3

Dose- vs Activity-Based Release Criteria

  • Dose: A more meaningful and direct

metric of radiation risk than activity

  • Patient activity does not predict dose to
  • ther individuals
  • ACMUI endorses current 10 CFR 35.75

dose-based release criteria

10 CFR 35.75 “30-mCi Rule”

slide-4
SLIDE 4

4

Dose-Based Release Criteria: Issues Associated with Outpatient Therapy

  • Negligible (<10%) dose contribution of

internalized contamination

  • Patient release to non-residence locales
  • Hotels
  • Patient transportation post-treatment
  • Public vs private
  • Patient vomiting post-treatment
  • Frequency uncertain
  • Clarity and consistency of post-release

precautions

  • NCRP Report 155
slide-5
SLIDE 5

5

Dose Contribution of Internalized Contamination

  • Significant peer-reviewed literature
  • >20 papers
  • Thyroid uptake measurements

 Range of precautions

  • Results consistent with minimal internal-

dose contribution

slide-6
SLIDE 6

Patient Release to Non-Residence Locales: Hotels

  • Activity for thyroid cancer: 175 mCi 131I
  • Internal dose negligible
  • Attenuation factors: Patient, 0.60; Walls, 0
  • Total-Body time-activity function: 95%, 8-hr Te; 5%, 7-day Te

Conservative Realistic

Activity excreted into bed linens 50 %/day 5 %/day Time workers hold linens (@ 0.3 m) 30 min/day 10 min/day Time workers/other guests @ 1 m 3 hr/day 1 hr/day from Patient Time patient and adjoining-room 12 hr/day 8 hr/day guests in respective beds (@ 2 m)

Illustrative Anaysis

slide-7
SLIDE 7

Patient Release to Non-Residence Locales: Hotels cont

Conservative Realistic EDE (mrem)

Days at hotel immediately post-therapy 1 2 3 1 2 3 Hotel Housekeeper 69 83 91 0.9 1.1 1.2 Hotel Laundry Worker 39 47 52 0.08 0.09 0.1 Guests in Adjoining Rooms 54 65 71 17 21 22 Other Hotel Workers / Other Guests 30 36 39 0.8 1.0 1.1

< 100 mrem

Results of Illustrative Anaysis

slide-8
SLIDE 8

8

Post

  • st-Ther

herapy y Transp anspor

  • rta

tation tion fr from

  • m Hospita

Hospital

(not inc (not included luded in Sub in Sub-Commi Committee ttee Repor eport) t)

  • Patients t

tients trea eated with ted with >100 >100 mCi mCi

  • Avoid
  • id public

public tr transpor ansporta tation tion

  • Avoid
  • id long (>1

long (>1 hr hr) ) trips trips

  • Travel

el in car sea in car seated ted alone in bac alone in back sea k seat

  • Driv

Driver er other th

  • ther than

an household memb household member er

  • Patients t

tients trea eated with ted with <100 <100 mCi mCi

  • No r

No restrict estrictions ions on

  • n

modes of modes of tr travel el

Culver and Dworkin. J Nucl Med 33: 1402, 1992 NCRP Report No 124, 1996

Doses from 131I-Treated Patients Immediately Post-Therapy 0.1 1 10 100 1000

1 2 3 4 5 Duration of Trip (hr) EDE (mrem)

Thyroid Cancer: 175 mCi

0.3 m 1 m

Hyperthyroidism: 10 mCi

0.3 m 1 m

slide-9
SLIDE 9

9

ACMUI’s Position

  • n Patient Release
  • Medical use of radionuclides safely serves

public interest and should not be burdened by excessive regulatory controls

  • Doses to other individuals from released

radioactive patients can be safely controlled by current dose-based 10 CFR 35.75 release criteria

slide-10
SLIDE 10

10

Abbr Abbreviat eviation ions s and and Acr Acronyms

  • nyms
  • ACMUI: Advisory Committee on Medical

Uses of Isotopes

  • CFR:

Code of Federal Regulations

  • EDE:

Effective dose equivalent

  • hr:

hour

  • NCRP:

National Council on Radiation Protection and Measurements

  • Te:

Effective half-life